References

1. G. Mugesh, W.-W. du Mont and H. Sies, Chem. Rev., 101, 2125-2179 (2001).

2. C.G. Jacob, G.I. Giles, N.M. Giles and H. Sies, Angew. Chem. Int. Ed., 42, 4742-4758 (2003).

3. A. Krief and L. Heven, Organoselenium Chemistry I: Functional Group Transformations, Springer-Verlag, Berlin, 1988.

4. P.A. Cox, The Elements on Earth, Oxford University Press, Oxford, 1995.

5. N.N. Greenwood and A. Earnshaw, Chemistry of the Elements, Pergamon Press, Oxford, 1984.

6. M. Birringer, S. Pilawa and L. Flohe, Nat. Prod. Rep., 19, 693-718 (2002).

7. K.F. Schwarz, C.M. Foltz, J. Am. Chem. Soc., 79, 3292-3293 (1957).

8. S.W. May, Exp. Opin. Invest. Drugs, 11, 1261-1269 (2002).

9. O.A. Levander, Biomed. Environ. Sci, 10, 214-219 (1997).

10. J. Alexander, J. Hogberg, Y. Thomassen and J. Aaseth, Selenium, Handbook of Toxicity of Inorganic Compounds, H.G. Seiler, H. Sigel and A. Sigel (eds), Marcel Dekker, New York, 1988.

11. D.G. Barceloux, J. Toxicol. Clin. Toxicol., 37, 145-172 (1999).

12. H.E. Ganther, D.G. Hafeman, N.G. Hoekstra et al., Selenium metabolism and function in man and animals, Trace Element Analytical Chemistry in Medicine and Biology, P. Bratter and P. Schramel (eds), Walter de Gruyter, New York, 1984.

13. I.S. Palmer, R.P. Gunsalus, A.W. Halverson and O.E. Olson, Biochim. Biophys. Acta, 208, 260-266 (1970).

14. R.S. Glass, W.P. Singh, W. Jung etal., Biochemistry, 32, 12555-12559 (1993).

15. S.W. May, Exp. Opin. Invest. Drugs, 8, 1017-1030 (1999).

16. H.E. Ganther, D.G. Hafeman, N.G. Hoekstra etal., Science, 179, 588-590 (1973).

17. R. Brigelius-Flohe, Free Rad. Biol. Med., 27, 951 (1999).

18. A. Lescure, D. Gautheret, P. Carbon and A. Krol, J. Biol. Chem., 274, 38147-38154 (1999).

19. L.B. Banu, M.J. Berry and P.R. Larsen, Nature, 349, 438-440 (1991).

20. J. Nordberg and E.S.J. Arner, Free Rad. Biol. Med., 31, 1287-1312 (2001).

21. J. Gailer, Appl. Organometal. Chem., 16, 701-707 (2002).

22. R.F. Burk, Curr. Opin. Gastroen., 17, 162-166 (2001).

23. M. Hirashima, T. Naruse, H. Maeda etal., Biol. Pharm. Bull., 26, 794-798 (2003).

24. K.E. Hill, J. Zhou, W.J. McMahan etal., J. Biol. Chem., 278, 13640-13646 (2003).

25. K.S. Zafar, A. Siddiqui, I. Sayeed etal., J. Neurochem., 84, 438-446 (2003).

27. M.P. Rayman, Proc. Nutr. Soc., 61, 203-215 (2002).

28. J.R. Arthur, R.C. McKenzie and G.J. Beckett, J. Nutr., 133, 1457S-1459S (2003).

29. R.W. Alexander, Hypertension, 25, 155-161 (1995).

30. J. Neve, Curr. Opin. Clin. Nutr., 5, 659 663 (2002).

31. G.N. Schrauzer, J. Nutr., 130, 1653-1656 (2000).

32. D.-W. Jeong, M.-H. Yoo, T.S. Kim etal., J. Biol. Chem., 277, 17871-17876 (2002).

34. M.A. Beck, P.C. Kolbeck, F.H. Rohr etal., J. Med. Virol., 43, 166-170 (1994).

35. M.A. Beck, R.S. Eswothy, Y.S. Ho and F.F. Chu, FASEB J., 12, 1143-1149 (1998).

36. M.A. Beck, H.K. Nelson, Q. Shi etal., FASEB J., 15, 1481-1483 (2001).

37. G.W. Pace and C.D. Leaf, Free Rad. Biol. Med., 19, 523-528 (1995).

38. L. Kiremidjian-Schumacher, R. Martin, H.I. Wishe etal., Biol. Trace Elem. Res., 41, 115-127 (1994).

39. L. Kiremidjian-Schumacher and M. Roy, BioFactors, 14, 161-168 (2001).

40. W. Wang, L. Yang, S. Hou etal., Curr. Sci., 81, 1215-1218 (2001).

41. L. Yang, W. Wang, S. Hou etal., Environ. Geochem. Hlth., 24, 359-374 (2002).

42. O.A. Levander and C.A. Baumann, Toxicol. Appl. Pharmacol., 9, 106-115 (1966).

43. O.A. Levander and C.A. Baumann, Toxicol. Appl. Pharmacol., 9, 98-105 (1966).

44. O.A. Levander and L.C Argrett, Toxicol. Appl. Pharmacol., 14, 308-314 (1969).

45. R.J. Shamberger and D.V. Frost, Can. Med. Assoc. J., 104, 82 (1969).

46. A.J. Duffield, C.D. Thomson, K.E. Hill and W. Sheila, Am. J. Clin. Nutr, 70, 896-903 (1999).

47. G.F. Combs and W.P. Gray, Pharmacol. Ther., 79, 179-192 (1998).

48. H.E. Ganther, Carcinogenesis, 20, 1657-1666 (1999).

49. H.E. Ganther and J.R. Lawrence, Tetrahedron, 53, 12299-12310 (1997).

50. C. Ip, R.M. Budnick and H.E. Ganther, Cancer Res., 51, 595-600 (1991).

51. C. Ip and H.E. Ganther, Cancer Res., 50, 1206-1211 (1990).

52. C. Ip, Y. Dong and H.E. Ganther, Cancer Met. Rev., 21, 281-289 (2002).

53. H.-M. Shen, W.-Z. Ding and C.-N. Ong, Free Rad. Biol. Med., 33, 552-561 (2002).

54. Z. Wang, C. Jiang and J. Lu, Mol. Carcinogenesis, 34, 113-120 (2002).

55. J.E. Spallholz, V.P. Palace and T.W. Reid, Biochem. Pharmacol., 67, 547-554 (2004).

56. Y.R. Seo, M.R. Kelley and M.L. Smith, Proc. Natl. Acad. Sci. USA, 99, 14548 (2002).

57. H.E. Ganther and C. Ip, J. Nutr., 131, 301-304 (2001).

58. S. Gromer and J.H. Gross, J. Biol. Chem, 277, 9701-9706 (2002).

60. C. Ip, H.J. Thompson, Z. Zhu and H.E. Ganther, Cancer Res., 60, 2882-2886 (2000).

61. J.E. Spallholz, T.W. Reid and R.D. Walkup, A Method of Using Synthetic L-Se-Methylselenocysteine as a Neutriceutical, EP 1205471, Eur. Pat. Appl., 2002.

62. J.M. Brown and B.G. Wouters, Cancer Res., 59, 1391-1399 (1999).

63. P.R. Harrison, J. Lanfear, L. Wu etal., Biomed. Environ. Sci., 10, 235-245 (1997).

64. J.E. Spallholz, Biomed. Environ. Sci., 10, 260-270 (1997).

65. M.S. Stewart, J.E. Spallholz, K.H. Neldner and B.C. Pence, Free Rad. Biol. Med., 26, 42-48 (1999).

66. R. Longtin, J. Natl. Cancer Inst., 95, 98-100 (2003).

67. M.L. Smith, J.M. Ford, M.C. Hollander etal., Mol. Cell. Biol., 20, 3705-3714 (2000).

68. K. Jonsson-Videsater, L. Bjorkhem-Bergman, A. Hossain etal., Biochem. Pharmacol., 67, 513-522 (2004).

69. M.M. Berggren, J.F. Mangin, J.R. Gasdaska and G. Powis, Biochem. Pharmacol., 57, 187-193 (1999).

70. E.M. Conner and M.B. Grisham, Nutrition, 12, 274-277 (1996).

71. F.A. Fitzpatrick, Int. Immunopharmacol., 1, 1651-1667 (2001).

72. T. Schewe, Gen. Pharmac., 26, 1153-1169 (1995).

73. Y. Nakamura, Q. Feng, T. Kumagai etal., J. Biol. Chem., 277, 2687-2694 (2002).

74. H. Sies and G.E. Arteel, Free Rad. Biol. Med., 28, 1451-1455 (2000).

75. H. Sies and H. Masumoto, Adv. Pharmacol., 38, 229-246 (1997).

76. G.E. Arteel, K. Briviba and H. Sies, Chem. Res. Toxicol., 12, 264-269 (1999).

77. D.G. Musaev, Y.V. Gelemtii, C.L. Hill and K. Hirao, J. Am. Chem. Soc., 125, 3877-3888 (2003).

78. D.G. Musaev and K. Hirao, J. Phys. Chem., 107, 1563-1573 (2003).

79. K.P. Sarker, K.K. Bismas, J.L. Rosales etal., J. Neurochem., 87, 1345-1353 (2003).

80. G. Mugesh and H.B. Singh, Chem. Soc. Rev., 29, 347-357 (2000).

81. I.A. Cotgreave, R. Morgenstern, L. Engman and J. Ahokas, Chem. Biol. Interact., 84, 69-76 (1992).

82. M. Maiorino, A. Roveri, M. Coassin and F. Ursini, Biochem. Pharmacol., 37, 2267-2271 (1988).

83. R. Morgenstern, I.A. Cotgreave and L. Engman, Chem. Biol. Interact., 84, 77-84 (1992).

84. I.A. Cotgreave, U. Johansson, G. Westergren etal., Agent. Action., 24, 313-319 (1988).

85. V. Galet, J.L. Bernier, J.P. Henichart etal., J. Med. Chem., 37, 2903-2911 (1994).

86. R. Zhao and A. Holmgren, J. Biol. Chem., 277, 39456-39462 (2002).

87. H. Kuhn and A. Borchert, Free Rad. Biol. Med., 33, 154-172 (2002).

88. B. Haribabu, M.W. Verghese, D.A. Steeber etal., J. Exp. Med., 192, 433-438 (2000).

89. Y. Liu, B. Li, L. Li and H.-Y. Zhang, Helv. Chim. Acta, 85, 9-18 (2002).

90. L. Engman, D. Stern, H. Frisell etal., Bioorg. Med. Chem., 3, 1255-1262 (1995).

91. J. Malmstrom, M. Jonsson, I.A. Cotgreave et al., J. Am. Chem. Soc., 123, 3434-3440 (2001).

92. T. Fenner and C.H. Schiesser, Molecules, 9, 472-479 (2004).

93. M.A. Lucas, O.T.K. Nguyen, C.H. Schiesser and S. Zheng, Tetrahedron, 56, 3995 (2000).

94. T.G. Back and Z. Moussa, J. Am. Chem. Soc., 125, 13455-13460 (2003).

95. T.G. Back and Z. Moussa, J. Am. Chem. Soc., 124, 12104-12105 (2002).

96. G. Gebeyehu, V.E. Marquez, A. Van Cott etal., J. Med. Chem., 28, 99-105 (1985).

97. M. Koketsu, H. Ishihara, W. Wu etal., Eur. J. Pharmac. Sci., 9, 157-161 (1999).

98. M. Rooseboom, G. Schaaf, J.N.M. Commandeur etal., J. Pharmacol. Exp. Ther., 301, 884-892 (2002).

99. M. Rooseboom, N.P.E. Vermeulen, I. Andreadou and J.N.M. Commandeur, J. Pharmacol. Exp. Ther., 294, 762 (2000).

100. J. Andreadou, W.M.P.B. Mange, J.N.M. Commandeur etal., J. Med. Chem., 39, 2040-2046 (1996).

101. C. Ip, Z. Zhu, H.J. Thompson etal., Anticancer Res., 19, 2875-2880 (1999).

102. P. Franchetti, L. Cappallecci, G.A. Sheikha etal., J. Med. Chem., 40, 1731-1737 (1997).

103. G.S. Baldew, J.G.J. Mol, F.J.J. de Kanter etal., Biochem. Pharmacol., 41, 1429-1437 (1991).

104. C.V. Rao, B. Simi, Y. Hirose etal., Int. J. Oncol., 16, 519-527 (2000).

105. S.W. May, K. Wimalasena, H.H. Herman etal., J. Med. Chem., 31, 1066-1068 (1988).

106. S.W. May, L. Wang, M.M. Gill-Woznichak etal., J. Pharmacol. Exp. Ther., 283, 470-477 (1997).

107. J.D. Overcast, A.E. Ensley, C.J. Buccafusco etal., J. Cardiovas. Pharmacol., 38, 337-346 (2001).

108. M.M. Woznichak, J.D. Overcast, K. Robertson etal., Arch. Biochem. Biophys., 379, 314-320 (2000).

109. M.J. Parhnam and E. Graf, Biochem. Pharmacol., 36, 3095-3102 (1987).

110. C.K. Chu, L. Ma, S. Olgen etal., J. Med. Chem., 43, 3906-3912 (2000).

111. M. Alpegiani, A. Bedeschi, E. Perrone and G. Franceschi, Tetrahedron Lett., 27, 3041-3044 (1986).

112. M.W. Carland, R.L. Martin and C.H. Schiesser, Tetrahedron Lett., 42, 4737-4739 (2001).

113. G.A. Brown, K.M. Anderson, M. Murray etal., Tetrahedron, 56, 5579-5587 (2000).

114. M. Koketsu, H. Ishihara and M. Hatsu, Res. Commun. Mol. Pathol. Pharmacol., 101, 179-186 (1998).

115. D. Dieidda, G. Lampis, C. Maullu etal., Pharmacol. Res., 36, 193-197 (1997).

116. R. Nozawa, T. Yokota and R. Fujimoto, Antimicrob. Agents Chemother., 33, 1388-1390 (1989).

Was this article helpful?

0 0
10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment